Naoyuki Okabe

1.2k total citations
56 papers, 706 citations indexed

About

Naoyuki Okabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Naoyuki Okabe has authored 56 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology. Recurrent topics in Naoyuki Okabe's work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Research Studies (11 papers). Naoyuki Okabe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Research Studies (11 papers). Naoyuki Okabe collaborates with scholars based in Japan, France and United States. Naoyuki Okabe's co-authors include Satoshi Muto, Takumi Yamaura, Mika Hoshino, Takeo Hasegawa, Jun Osugi, Hiroyuki Suzuki, Yuki Matsumura, Yutaka Shio, Hiroyuki Suzuki and Mitsuro Fukuhara and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Naoyuki Okabe

49 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoyuki Okabe Japan 15 392 255 212 197 173 56 706
И. Г. Козлов Russia 7 413 1.1× 276 1.1× 339 1.6× 223 1.1× 258 1.5× 43 852
Yuzi Zhang China 14 568 1.4× 187 0.7× 213 1.0× 188 1.0× 176 1.0× 45 797
Satoshi Muto Japan 18 406 1.0× 311 1.2× 246 1.2× 223 1.1× 229 1.3× 72 898
Marissa S. Mattar United States 12 313 0.8× 230 0.9× 290 1.4× 175 0.9× 153 0.9× 22 666
Wen Liu China 15 525 1.3× 210 0.8× 407 1.9× 182 0.9× 94 0.5× 59 885
Stephanie Du Four Belgium 15 435 1.1× 231 0.9× 287 1.4× 104 0.5× 264 1.5× 34 834
Zoila A. Lopez‐Bujanda United States 11 409 1.0× 197 0.8× 275 1.3× 213 1.1× 291 1.7× 18 731
Takumi Yamaura Japan 13 329 0.8× 215 0.8× 200 0.9× 172 0.9× 156 0.9× 38 603
Christian Britschgi Switzerland 17 413 1.1× 289 1.1× 272 1.3× 101 0.5× 145 0.8× 59 770
Angel Qin United States 12 343 0.9× 201 0.8× 178 0.8× 122 0.6× 94 0.5× 33 561

Countries citing papers authored by Naoyuki Okabe

Since Specialization
Citations

This map shows the geographic impact of Naoyuki Okabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyuki Okabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyuki Okabe more than expected).

Fields of papers citing papers by Naoyuki Okabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoyuki Okabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyuki Okabe. The network helps show where Naoyuki Okabe may publish in the future.

Co-authorship network of co-authors of Naoyuki Okabe

This figure shows the co-authorship network connecting the top 25 collaborators of Naoyuki Okabe. A scholar is included among the top collaborators of Naoyuki Okabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoyuki Okabe. Naoyuki Okabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muto, Satoshi, Yuki Ozaki, Hikaru Yamaguchi, et al.. (2025). Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer. Cancer Diagnosis & Prognosis. 5(1). 32–41. 1 indexed citations
2.
Matsumura, Yuki, Mitsuro Fukuhara, Hikaru Yamaguchi, et al.. (2022). Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips. Journal of Cardiothoracic Surgery. 17(1). 143–143. 2 indexed citations
3.
Matsumura, Yuki, Yasuyuki Kobayashi, Hikaru Yamaguchi, et al.. (2022). Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report. Thoracic Cancer. 13(21). 3076–3079. 3 indexed citations
4.
Watanabe, Masayuki, Yuki Matsumura, Hikaru Yamaguchi, et al.. (2022). Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Thoracic Cancer. 13(19). 2817–2822. 1 indexed citations
5.
Takagi, Hironori, Satoshi Muto, Hikaru Yamaguchi, et al.. (2021). Our experience of lung resection in patients who decline blood transfusion for religious reasons. General Thoracic and Cardiovascular Surgery. 69(7). 1105–1111. 2 indexed citations
6.
Matsumura, Yuki, Hironori Takagi, Masayuki Watanabe, et al.. (2021). MA09.05 PD1-Positive Tertiary Lymphoid Structure as a Predictive Factor of Durable Clinical Effect in Immunotherapy for NSCLC. Journal of Thoracic Oncology. 16(10). S912–S912. 2 indexed citations
7.
Ozaki, Yuki, Satoshi Muto, Hironori Takagi, et al.. (2019). Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer. Cancer Immunology Immunotherapy. 69(1). 127–134. 36 indexed citations
8.
Hasegawa, Takeo, Yuki Ozaki, Takuya Inoue, et al.. (2019). Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature. Journal of Medical Case Reports. 13(1). 21 indexed citations
9.
Takeda, Kazuyoshi, Kazutaka Kitaura, Ryuji Suzuki, et al.. (2018). Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination. Cancer Immunology Immunotherapy. 67(6). 949–964. 11 indexed citations
10.
Muto, Satoshi, Hironori Takagi, Takuya Inoue, et al.. (2018). Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report. Journal of Thoracic Oncology. 13(8). 1217–1221. 109 indexed citations
11.
Okabe, Naoyuki, et al.. (2018). Garcin syndrome caused by sphenoid bone metastasis of lung cancer: a case study. World Journal of Surgical Oncology. 16(1). 46–46. 4 indexed citations
12.
Matsumura, Yuki, Takuya Inoue, Yuzuru Watanabe, et al.. (2017). Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma. Interactive Cardiovascular and Thoracic Surgery. 25(5). 690–695. 3 indexed citations
13.
Muto, Satoshi, Hironori Takagi, Takuya Inoue, et al.. (2017). Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients. Anticancer Research. 37(6). 3169–3174. 9 indexed citations
14.
Osugi, Jun, Takumi Yamaura, Satoshi Muto, et al.. (2016). Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report. Case Reports in Oncology. 9(1). 51–55. 5 indexed citations
15.
Inoue, Takuya, Yuzuru Watanabe, Satoshi Muto, et al.. (2016). Recurrent Intrapulmonary Solitary Fibrous Tumor With Malignant Transformation. The Annals of Thoracic Surgery. 102(1). e43–e45. 8 indexed citations
16.
Osugi, Jun, Takumi Yamaura, Satoshi Muto, et al.. (2015). Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer. Lung Cancer. 88(3). 310–318. 53 indexed citations
17.
Okabe, Naoyuki, Junji Ezaki, Takumi Yamaura, et al.. (2015). FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma. International Journal of Oncology. 46(3). 999–1006. 40 indexed citations
18.
Hasegawa, Takeo, et al.. (2014). A case of primary pulmonary synovial sarcoma initially diagnosed as a benign lung tumor due to calcification of the tumor. The Journal of the Japanese Association for Chest Surgery. 28(4). 488–494.
19.
Watanabe, Yuzuru, Naoyuki Okabe, Takeo Hasegawa, Jun Osugi, & Hiroyuki Suzuki. (2013). A case of surgically treated Good syndrome. The Journal of the Japanese Association for Chest Surgery. 27(1). 106–112.
20.
Osugi, Jun, et al.. (2013). A case of thymoma arising in a unilocular thymic cyst. The Journal of the Japanese Association for Chest Surgery. 27(4). 522–527.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by И. Г. Козлов Breakdown of academic impact, for papers by Yuzi Zhang Breakdown of academic impact, for papers by Satoshi Muto Breakdown of academic impact, for papers by Marissa S. Mattar Breakdown of academic impact, for papers by Wen Liu Breakdown of academic impact, for papers by Stephanie Du Four Breakdown of academic impact, for papers by Zoila A. Lopez‐Bujanda Breakdown of academic impact, for papers by Takumi Yamaura Breakdown of academic impact, for papers by Christian Britschgi Breakdown of academic impact, for papers by Angel Qin
Rankless by CCL
2026